Skip to content

Cardinal Health to extend pharmaceutical distribution agreements with CVS Health

Binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032.

DUBLIN, Ohio – Cardinal Health has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.

Cardinal Health Logo

"We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.

In connection with the renewal, Cardinal Health has reaffirmed its fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth ($12.40 to $12.60) and its long-term non-GAAP EPS growth rate guidance of 12% to 14%. Further updates may be provided during the company's upcoming first quarter earnings call on November 5, 2026.

Latest